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A need to reconsider guidelines on
management of primary spontaneous
pneumothorax?
Jiyoon Yoon1†, Parthipan Sivakumar1*† , Kevin O’Kane2 and Liju Ahmed1
Abstract
Background: The key guidelines in the management of primary spontaneous pneumothorax (PSP) include the
2010 British Thoracic Society (BTS) Pleural Disease guideline and 2001 American College of Chest Physicians (ACCP)
Consensus Statement. Current recommendations are dependent on radiographic measures which differ between
these two guidelines. The aim of this study is to compare size classification of PSP cases, according to BTS and
ACCP guidelines, and to evaluate guideline compliance.
Findings: We conducted a retrospective evaluation of all PSP episodes presenting to St Thomas’ Hospital, London,
between February 2013 and December 2014. Data was recorded from review of chest X-rays and patient records.
Eighty-seven episodes of PSP in 72 patients were identified (median age 25 years, IQR 22–32.25). Classification of
“large” and “small” showed the greatest disparity in those managed conservatively (12/27, 44%) or with aspiration
only (11/23, 48%). In this UK study, BTS guidelines were followed in 70% of episodes with adherence to ACCP
guidelines in 32% of episodes.
Conclusions: There is a poor agreement in size classification between BTS and ACCP guidelines, resulting in
conflicting recommendations for management of PSP. Robust clinical trial evidence is required to achieve
international consensus on the management of PSP.
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Introduction
Primary spontaneous pneumothorax (PSP) is a condition
that affects young, otherwise healthy people. A recent
large epidemiological study reports an annual incidence
of 22.7 per 100,000 and a sex ratio of 1:3.3 (women:
men) [1]. Guidelines for the management of PSP include
those produced by the British Thoracic Society (BTS) [2]
and the American College of Chest Physicians (ACCP)
[3]. A key distinction made in treatment of clinically
asymptomatic patients is the size of the PSP, with ‘large’
defined as greater than 2 cm rim at the hilum (BTS) or
greater than 3 cm apex-to-cupola distance (ACCP). We
evaluated the classification and management of PSP
according to the two guidelines in a local cohort.
Methods
Data was collected retrospectively from Emergency
Department (ED) electronic records of St Thomas’
Hospital, London. All patients diagnosed with pneumo-
thorax, between February 2013 and December 2014,
were included, with exception of individuals over
50 years with significant smoking history (>20 pack years
and current smokers, where records were unclear), or
underlying lung disease (not including previous pneumo-
thorax). Immediate recurrence was defined as a re-attendance
within 30 days of the first episode. Guideline adherence is
defined in Table 1. Electronic patient records, including
admission notes, chest radiographs, dates of admis-
sion and follow-up clinic notes were used to gather
data.
Findings
Eighty-seven episodes of PSP presenting to ED in 72
patients were identified (Table 2). Median age was
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25 years (IQR 22–32.25), and 62 patients were male.
BTS and ACCP guidelines conflicted on size classifica-
tion in 30 episodes (34%). In this UK-based study,
management was predominantly in line with the BTS
guidelines over ACCP, with 70% overall compliance rate.
Twenty-seven episodes were conservatively managed,
all of which were classified as small according to BTS. In
12 episodes (44%), ACCP classification conflicted with
BTS. Despite this, all episodes were managed according to
BTS guidelines.
Management of PSP by needle aspiration (NA) only
met BTS guidelines in 14/23 episodes (61%). Disparity
in classification was highest among the treatment
groups, at 11/23 (48%). Those episodes that underwent
needle aspiration contrary to BTS guidance (classified
as ‘small’) had ‘large’ pneumothoraces according to
ACCP guidelines.
Fifteen episodes were managed with standard intercos-
tal chest drain (ICD) insertion; 7/15 episodes (47%) were
compliant with BTS guidelines. Eight cases were non-
compliant due to insertion of drain without prior NA.
Of these, 5 were symptomatic or clinically unstable.
In 22 cases, an ambulatory device (Atrium pneumo-
stat) was attached to a standard ICD. Of these, 18
underwent standard drain insertion, which was subse-
quently attached to an ambulatory device during ad-
mission to allow early discharge. Four cases were
ambulated in the first instance. Although ambulatory
management does not feature in the guidelines, the
indication for initial ICD insertion followed BTS
guidelines in 13 of 22 episodes (59%). Of the
remaining 9 episodes, 2 had ‘small’ PSP according to
BTS but were classified as ‘large’ according to ACCP
and underwent ICD insertion. Two episodes had
‘small’ PSP according to both guidelines but had his-
tory of recurrent PSP and previous pleurodesis and
had ICDs inserted. Five had ‘large’ PSP and did not
undergo NA prior to ICD insertion; four of these
episodes were symptomatic.
Discussion
Significant deviation from BTS guidelines can be seen
throughout the groups studied. We observe two major
patterns of non-adherence.
Firstly, NA is frequently omitted in favour of ICD in
‘large’ PSP. Reasons for deviation are unclear but may be
due to physicians choosing to pursue a ‘single definitive
procedure’. Overall, the management of 26 PSP episodes
deviated from BTS guidelines. Among these, 9/26 (35%)
were symptomatic or clinically unstable, all of which had
ICD insertion with omission of NA.
Prospective data on the efficacy of NA in comparison
to ICD is conflicting. Noppen et al. found no difference
between NA and ICD on success of the procedure (93
and 85%, p = 0.4) [4]. However Andrivet et al. found
significantly lower success in NA than with ICD (67 and
93%, p = 0.01) [5], although the authors note more
stringent criteria for NA compared to ICD (declared as
failure after a maximum aspiration period of 60 min vs
10-day period, respectively).
Table 1 Summary of the BTS and ACCP guidance on the
management of primary spontaneous pneumothorax
Size of
pneumothorax
BTS ACCP
Stablea and
asymptomatic
Small No intervention No intervention
Large 1. Needle aspiration
If fails
2. Intercostal chest
drain
Intercostal chest
drain
Unstable or
breathless
NA 1. Needle aspiration
If fails
2. Intercostal chest
drain
Intercostal chest
drain
aStable fulfilling all criteria - Respiratory rate <24 breaths/min; heart rate 60–
120 bpm; O2 saturation >90% on room air; blood pressure >90/60; able to
complete full sentences between breaths
Table 2 Disparity in size classification in the differing treatment groups and adherence to BTS and ACCP guidance
Treatment Total Classified as ‘large’ (%) Disparity in classification (%) BTS guidelines
followed (%)
ACCP guidelines
followed (%)BTS ACCP
Whole group 87 40 (46) 67 (77) 30 (34) 61 (70) 28 (32)
Conservative 27 0 (0) 11 (41) 12 (44) 27 (100) 16 (59)
Needle aspiration
only
23 10 (43) 23 (100) 11 (48) 14 (61) 0a
Intercostal chest drain
(all)
37 30 (81) 33 (89) 7 (19) 20 (54) 12 (32)
ICD with inpatient stay 15 13 (87) 14 (93) 3 (20) 7 (47) 8 (53)
ICD with outpatient
management
22 17 (77) 19 (86) 4 (18) 13 (59) 4 (18)
aACCP guidelines do not recommend aspiration
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This uncertainty is reflected in the ACCP consen-
sus statement [3], which states NA is inappropriate
in most cases, with the exception of stable patients
with a ‘small’ pneumothorax that expands during
observation.
Although data on efficacy of NA differ, studies suggest
that given minimal complications, possible decrease in
hospitalisation (52 vs 100%, p < 0.0001) [4], decreased
pain [6], and no difference in recurrence rate [4–6], NA
is a simple and safe first-line treatment for PSP.
Secondly, apical pneumothoraces are poorly repre-
sented in the size classification in BTS guidelines. All
cases non-compliant with guidelines in the NA group
had ‘small’ PSP according to BTS but ‘large’ accord-
ing to ACCP, which favours apical pneumothorax
identification.
Collins et al. quantified the difference in size of PSP
classified as ‘large’ under different international guide-
lines using the volumetrically-derived Collins’ method
[7]. The median size of ‘large’ PSP was estimated to be
95 and 31% of the volume of the hemithorax, for BTS
and ACCP, respectively [8].
Our data shows marked disagreement in size classifi-
cation within the group that is conservatively managed
which may reflect the impact of clinical judgement.
Given that size classification shows such disparity, it is
likely that many patients with ‘large’ PSP, by either
standard, are routinely being managed conservatively
without adverse consequences. This emphasises the
importance of clinician experience and sound decision
making in the safe management of PSP. Despite this,
there is a paucity of high-quality data regarding the
efficacy and safety of conservative vs interventional
treatment of PSP, with a recent Cochrane review finding
no admissible studies for meta-analysis [9]. Perhaps a
study comparing symptom directed management with
current guidance would be suitably placed to answer
this question.
In our study, we also included patients treated on an
ambulatory basis, a pathway currently being prospect-
ively evaluated for safety and efficacy [10]. Whilst
guidelines cannot aim to encompass every clinical
scenario, especially in the light of new developments,
there is currently lack of standardisation. This not
only affects clinical practice but also limits availability
of comparable data.
Fundamental to dealing with uncertainty is acknowledg-
ing the limitation of conventional wisdom. Before guide-
lines can be revised, there is a case to be made for seeking
robust clinical trial evidence, a scientific endeavour
currently undertaken by the Randomised Ambulatory
Management of Primary Pneumothorax study (RAMPP)
[10]. Then only may we reach an elegant international
consensus with which to direct management.
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